Research progress of inflammatory response of adipose tissue

Abstract

Abstract: This review reported lipid mediators associated with inflammatory responses in adipose tissue, pro-inflammatory mediators: eicosane compounds derived from cyclooxy-genase (e.g. prostaglandins); Pro-resolving mediators: lipoxins produced by omega-6 polyunsaturated fatty acids, and resolvins produced by omega-3 polyunsaturated fatty acids. The treatment of inflammatory responses should not be limited to the use of acute cascade antagonists or inhibitors, but should be expanded to take into account the great therapeutic potential of inducers or agonists in the inflammatory resolution phase.

Key words: obesity, adipose tissue, acute inflammatory response, resolution

CLC Number:

R363.1

SHU Feng, WANG Meng-yi, ZHANG Shi-wu, LI Qian-zhu, ZHANG Wei-hua. Research progress of inflammatory response of adipose tissue[J]. Basic & Clinical Medicine, 2021, 41(7): 1052-1055.

References

[1]GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years[J]. N Engl J Med, 2017,377:13-27.
[2]Tang EH, Cai Y, Wong CK, et al. Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue[J]. J Lipid Res, 2015,56:358-368.
[3]Chan PC, Hsiao FC, Chang HM, et al. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prosta-glandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance[J]. FASEB J, 2016,30:2282-2297.
[4]Hu X, Cifarelli V, Sun S, et al. Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitment[J]. J Lipid Res, 2016,57:663-673.
[5]Börgeson E, McGillicuddy FC, Harford KA, et al. Lipoxin A4 attenuates adipose inflammation[J]. FASEB J, 2012,26:4287-4294.
[6]Börgeson E, Johnson AM, Lee YS, et al. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease[J]. Cell Metab, 2015,22:125-137.
[7]Arita M, Ohira T, Sun YP, et al. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation[J]. J Immunol, 2007,178:3912-3917.
[8]Titos E, Rius B, González-Périz A, et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype[J]. J Immunol, 2011,187:5408-5418.
[9]Titos E, Rius B, López-Vicario C, et al. Signaling and immunoresolving actions of resolvin D1 in inflamed human visceral adipose tissue[J]. J Immunol, 2016,197:3360-3370.
[10]Chiurchiù V, Leuti A, Dalli J, et al. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses[J]. Sci Transl Med, 2016,8:353ra111. doi: 10.1126/scitranslmed.aaf7483.
[11]Sulciner ML, Serhan CN, Gilligan MM, et al. Resolvins suppress tumor growth and enhance cancer therapy[J]. J Exp Med, 2018,215:115-140.
[12]Serhan CN, Gotlinger K, Hong S, et al. Anti-inflam-matory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes[J]. J Immunol, 2006,176:1848-1859.
[13]Serhan CN, Dalli J, Colas RA, et al. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome[J]. Biochim Biophys Acta, 2015,1851:397-413.
[14]Aursnes M, Tungen JE, Colas RA, et al. Synthesis of the 16S,17S-epoxyprotectin intermediate in the biosynthesis of protectins by human macrophages[J]. J Nat Prod, 2015,78:2924-2931.
[15]Dalli J, Colas RA, Quintana C, et al. Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes[J]. Crit Care Med, 2017,45:58-68.
[16]Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms[J]. FASEB J, 2017,31:1273-1288.
[17]Serhan CN, Yang R, Martinod K, et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions[J]. J Exp Med, 2009,206:15-23.
[18]Serhan CN, Dalli J, Karamnov S, et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain[J]. FASEB J, 2012,26:1755-1765.
[19]Deng B, Wang CW, Arnardottir HH, et al. Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages[J]. PLoS One, 2014,9:e102362.doi: 10.1371/journal.pone.0102362.
[20]Dalli J, Vlasakov I, Riley IR, et al. Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages[J]. Proc Natl Acad Sci U S A, 2016,113:12232-12237.
[21]Francos-Quijorna I, Santos-Nogueira E, Gronert K, et al. Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury[J]. J Neurosci, 2017,37:11731-11743.